Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Current Vascular Pharmacology | journal | 1.362 Q1 | 69 | 33 | 116 | 3168 | 482 | 111 | 4.51 | 96.00 | |
52 | Drug Discovery Today | journal | 1.362 Q1 | 215 | 148 | 861 | 7463 | 2772 | 715 | 4.35 | 50.43 | |
53 | Pharmacogenomics Journal | journal | 1.305 Q1 | 95 | 43 | 157 | 2569 | 749 | 146 | 5.40 | 59.74 | |
54 | CNS Drug Reviews | journal | 1.292 Q1 | 64 | 26 | 69 | 2174 | 256 | 67 | 3.87 | 83.62 | |
55 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.291 Q1 | 150 | 273 | 555 | 11234 | 1902 | 535 | 3.36 | 41.15 | |
56 | Journal of Natural Products | journal | 1.255 Q1 | 161 | 406 | 1220 | 10111 | 3485 | 1214 | 2.82 | 24.90 | |
57 | Clinical Therapeutics | journal | 1.247 Q1 | 150 | 296 | 592 | 9610 | 2486 | 531 | 3.92 | 32.47 | |
58 | Drug Safety | journal | 1.235 Q1 | 140 | 108 | 273 | 4980 | 1105 | 248 | 3.80 | 46.11 | |
59 | Inflammation and Allergy - Drug Targets | journal | 1.235 Q1 | 55 | 30 | 32 | 2674 | 92 | 28 | 2.88 | 89.13 | |
60 | Behavioural Pharmacology | journal | 1.194 Q1 | 87 | 84 | 218 | 4643 | 574 | 208 | 2.50 | 55.27 | |
61 | Expert Opinion on Investigational Drugs | journal | 1.190 Q1 | 117 | 170 | 411 | 12057 | 1514 | 390 | 3.87 | 70.92 | |
62 | Infectious Disorders - Drug Targets | journal | 1.158 Q1 | 61 | 35 | 89 | 3848 | 270 | 83 | 2.97 | 109.94 | |
63 | Addiction Biology | journal | 1.142 Q1 | 93 | 36 | 114 | 2655 | 318 | 100 | 2.80 | 73.75 | |
64 | Investigational New Drugs | journal | 1.131 Q1 | 97 | 70 | 183 | 1837 | 575 | 180 | 3.33 | 26.24 | |
65 | PharmacoEconomics | journal | 1.129 Q1 | 118 | 84 | 368 | 3733 | 994 | 318 | 2.45 | 44.44 | |
66 | Clinical Trials | journal | 1.119 Q1 | 74 | 60 | 177 | 1519 | 290 | 162 | 1.66 | 25.32 | |
67 | Mini-Reviews in Medicinal Chemistry | journal | 1.113 Q1 | 107 | 114 | 339 | 11701 | 1183 | 322 | 3.32 | 102.64 | |
68 | Pharmacology Biochemistry and Behavior | journal | 1.095 Q1 | 148 | 176 | 814 | 9717 | 2167 | 811 | 2.60 | 55.21 | |
69 | Expert Opinion on Biological Therapy | journal | 1.092 Q1 | 102 | 165 | 428 | 13835 | 1378 | 425 | 3.12 | 83.85 | |
70 | Journal of Pharmacological Sciences | journal | 1.089 Q1 | 101 | 164 | 585 | 5227 | 1591 | 576 | 2.73 | 31.87 | |
71 | Reviews in Contemporary Pharmacotherapy | journal | 1.077 Q1 | 18 | 0 | 1 | 0 | 3 | 1 | 0.00 | 0.00 | |
72 | Antiviral Research | journal | 1.064 Q1 | 151 | 114 | 285 | 4393 | 1013 | 283 | 3.83 | 38.54 | |
73 | Cancer Chemotherapy and Pharmacology | journal | 1.053 Q1 | 122 | 193 | 564 | 6080 | 1578 | 560 | 2.83 | 31.50 | |
74 | Microbial Drug Resistance | journal | 1.042 Q1 | 78 | 43 | 156 | 1347 | 326 | 156 | 1.90 | 31.33 | |
75 | Current Opinion in Investigational Drugs | journal | 1.033 Q1 | 83 | 113 | 438 | 6943 | 1272 | 406 | 3.04 | 61.44 | |
76 | Prostaglandins and Other Lipid Mediators | journal | 1.017 Q1 | 86 | 76 | 159 | 3580 | 358 | 157 | 2.17 | 47.11 | |
77 | European Journal of Pharmacology | journal | 1.002 Q2 | 203 | 740 | 2146 | 28348 | 6199 | 2138 | 2.63 | 38.31 | |
78 | Journal of Biomolecular Screening | journal | 0.998 Q2 | 86 | 108 | 253 | 2743 | 682 | 251 | 2.48 | 25.40 | |
79 | Pharmacological Research | journal | 0.986 Q2 | 169 | 134 | 429 | 8239 | 1346 | 423 | 3.02 | 61.49 | |
80 | Current Opinion in Molecular Therapeutics | journal | 0.985 Q2 | 67 | 72 | 238 | 4448 | 607 | 213 | 2.54 | 61.78 | |
81 | Progress in Medicinal Chemistry | journal | 0.981 Q2 | 38 | 5 | 23 | 777 | 54 | 20 | 2.88 | 155.40 | |
82 | Anti-Cancer Drugs | journal | 0.974 Q2 | 102 | 151 | 431 | 5734 | 1121 | 429 | 2.69 | 37.97 | |
83 | Pharmacogenomics | journal | 0.973 Q2 | 100 | 171 | 302 | 8444 | 1021 | 273 | 3.31 | 49.38 | |
84 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.970 Q2 | 57 | 34 | 122 | 1317 | 233 | 111 | 1.95 | 38.74 | |
85 | Experimental and Clinical Psychopharmacology | journal | 0.964 Q2 | 101 | 60 | 124 | 3417 | 301 | 123 | 2.30 | 56.95 | |
86 | Vascular Pharmacology | journal | 0.959 Q2 | 108 | 107 | 233 | 4006 | 597 | 225 | 2.71 | 37.44 | |
87 | Clinical Neuropharmacology | journal | 0.955 Q2 | 85 | 59 | 197 | 1465 | 613 | 186 | 2.84 | 24.83 | |
88 | Expert Opinion on Emerging Drugs | journal | 0.950 Q2 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 | |
89 | British Journal of Clinical Pharmacology | journal | 0.934 Q2 | 167 | 230 | 634 | 5435 | 1814 | 522 | 2.65 | 23.63 | |
90 | Journal of Ethnopharmacology | journal | 0.905 Q2 | 231 | 483 | 1192 | 17312 | 3437 | 1178 | 2.62 | 35.84 | |
91 | Chirality | journal | 0.891 Q2 | 83 | 107 | 321 | 3836 | 706 | 319 | 2.49 | 35.85 | |
92 | Bulletin of Mathematical Biology | journal | 0.885 Q2 | 97 | 115 | 247 | 4155 | 528 | 244 | 1.84 | 36.13 | |
93 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.866 Q2 | 45 | 32 | 115 | 3098 | 306 | 108 | 2.62 | 96.81 | |
94 | Clinical and Experimental Pharmacology and Physiology | journal | 0.866 Q2 | 115 | 255 | 563 | 9355 | 1279 | 555 | 2.33 | 36.69 | |
95 | American Journal of PharmacoGenomics | journal | 0.858 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
96 | Journal of Clinical Pharmacology | journal | 0.848 Q2 | 130 | 159 | 450 | 4511 | 1466 | 441 | 3.33 | 28.37 | |
97 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.847 Q2 | 99 | 78 | 324 | 4878 | 891 | 315 | 2.35 | 62.54 | |
98 | European Journal of Medicinal Chemistry | journal | 0.842 Q2 | 203 | 160 | 444 | 4962 | 1132 | 444 | 2.41 | 31.01 | |
99 | Planta Medica | journal | 0.839 Q2 | 135 | 236 | 757 | 5684 | 1744 | 747 | 2.02 | 24.08 | |
100 | International Immunopharmacology | journal | 0.836 Q2 | 149 | 214 | 610 | 8640 | 1540 | 595 | 2.36 | 40.37 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®